Stockholders' Deficiency (Details Narrative) (USD $)	3 Months Ended					12 Months Ended	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014 Stock Warrants [Member]	Mar. 31, 2013 Stock Warrants [Member]	Mar. 31, 2014 Series B Preferred Stock [Member]	Dec. 31, 2013 Series B Preferred Stock [Member]	Mar. 31, 2014 Stock Option [Member]	Mar. 31, 2013 Stock Option [Member]
Preferred Stock Contractual Dividends					74,730	279,380
Weighted Average Fair Value			$ 0.23	$ 1.38
Selling, General And Administrative Expenses			$ 264	$ 504,777			$ 151,853	$ 312,444
Stock-Based Compensation Expense related to stock options, unamortized							1,476,372
Stock-Based Compensation Expense, amortized			3,685				584,803
Stock-based compensation expense warrants. unamortized			580,525
Weighted Average Remaining Period			1 year 6 months				1 year 6 months
Performance based option vesting			576,840				891,569
Salary expense	$ 87,500	$ 87,500